Two Sigma Investments LP Sells 21,924 Shares of Iradimed Corporation (NASDAQ:IRMD)

Two Sigma Investments LP reduced its position in shares of Iradimed Corporation (NASDAQ:IRMD - Free Report) by 54.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 18,498 shares of the medical equipment provider's stock after selling 21,924 shares during the period. Two Sigma Investments LP owned approximately 0.15% of Iradimed worth $1,017,000 at the end of the most recent reporting period.

Other large investors have also recently modified their holdings of the company. US Bancorp DE raised its stake in Iradimed by 476.6% during the fourth quarter. US Bancorp DE now owns 617 shares of the medical equipment provider's stock worth $34,000 after acquiring an additional 510 shares in the last quarter. Huntington National Bank grew its holdings in shares of Iradimed by 34.0% during the 4th quarter. Huntington National Bank now owns 1,993 shares of the medical equipment provider's stock valued at $110,000 after purchasing an additional 506 shares during the last quarter. State of Wyoming acquired a new position in Iradimed during the 4th quarter worth approximately $149,000. Avantax Advisory Services Inc. bought a new position in Iradimed in the 4th quarter valued at approximately $217,000. Finally, Bessemer Group Inc. lifted its stake in Iradimed by 9.6% in the 4th quarter. Bessemer Group Inc. now owns 4,143 shares of the medical equipment provider's stock valued at $228,000 after purchasing an additional 362 shares during the last quarter. Institutional investors and hedge funds own 92.34% of the company's stock.

Wall Street Analyst Weigh In

IRMD has been the subject of several research analyst reports. Roth Mkm reiterated a "buy" rating and set a $72.00 price target (up from $60.00) on shares of Iradimed in a report on Friday, February 14th. Wall Street Zen raised Iradimed from a "buy" rating to a "strong-buy" rating in a report on Tuesday, May 6th.

Iradimed Price Performance

NASDAQ IRMD traded up $0.30 during trading hours on Monday, reaching $60.80. The company's stock had a trading volume of 36,303 shares, compared to its average volume of 43,294. The stock has a market cap of $773.07 million, a P/E ratio of 40.53 and a beta of 0.92. The firm has a fifty day simple moving average of $53.09 and a 200-day simple moving average of $54.68. Iradimed Corporation has a 52 week low of $41.71 and a 52 week high of $63.29.

Iradimed Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, May 30th. Shareholders of record on Tuesday, May 20th were issued a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a yield of 1.12%. The ex-dividend date was Tuesday, May 20th. Iradimed's payout ratio is presently 43.87%.

Iradimed Company Profile

IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.